Axsome: Q4 Earnings Snapshot

SelfRugger · 2026-03-02T07:32:50+00:00

Axsome Therapeutics reported a fourth-quarter loss of $28.6 million, or 56 cents per share, which was higher than expectations. However, revenue reached $196 million, exceeding forecasts. Over the year, losses narrowed to $183.2 million with revenues of $638.5 million.

SelfRugger

2026-03-02 07:32:50

Abstract generation in progress

Axsome: Q4 Earnings Snapshot

Associated Press Finance

Mon, February 23, 2026 at 11:47 PM GMT+9 1 min read

In this article:

AXSM

-3.56%

NEW YORK (AP) — NEW YORK (AP) — Axsome Therapeutics Inc. (AXSM) on Monday reported a loss of $28.6 million in its fourth quarter.

The New York-based company said it had a loss of 56 cents per share. Losses, adjusted for non-recurring gains, came to 71 cents per share.

The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 70 cents per share.

The biopharmaceutical company posted revenue of $196 million in the period, topping Street forecasts. Ten analysts surveyed by Zacks expected $193 million.

For the year, the company reported that its loss narrowed to $183.2 million, or $3.68 per share. Revenue was reported as $638.5 million.

Axsome shares have climbed nearly 1% since the beginning of the year. The stock has climbed 33% in the last 12 months.

This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on AXSM at

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes